600285-基本财务实时评分详情
羚锐制药600285基本财务实时评分详情
更新时间:2021-11-27 00:00:01
股票代码
600285
当期评分
股票名称
羚锐制药
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)0.74390.79280.59550.59550.5955
销售净利润率(%)11.970413.590115.337215.337215.3372
销售毛利率(%)74.470375.695376.868476.868476.8684
净资产收益率(%)11.6813.3211.8711.8711.87
营业增长率(%)11.06765.06253.45243.45243.4524
净利润增长率(%)9.264319.27822.96442.96442.9644
每股收益(%)0.4120.5120.4750.3120.135
现金流量比率(%)46.280344.403132.880719.474512.1704
三项费用比重(%)58.08656.486456.312555.624555.4915
每股净资产(¥)3.55043.8923.9993.85634.0186
流动比率(%)1.69191.73051.82621.69591.7248
速动比率(%)1.34841.44771.53721.41951.4607
现金比率(%)67.898573.112875.375766.189466.1894
总资产利润率(%)7.65929.12418.0145.30182.2308
主营利润比重%539.5905478.4247427.3322429.7636416.5771
应收账款(万元)18,668.8817,251.1420,477.1832,185.9623,578.39
应收票据(万元)37,409.3044,698.3947,465.6231,873.8736,803.28
预付款项(万元)1,873.802,148.752,542.984,665.242,507.77
存货(万元)32,380.3928,668.1429,714.9029,697.4930,261.14
在建工程(万元)789.74903.232,905.102,007.551,015.68
应付款项(万元)5,829.376,765.996,434.526,466.505,370.75
长期借款(万元)----------
未分配利润(万元)82,315.90100,138.93110,061.66100,842.12107,792.33
商誉(万元)50.0050.0050.0050.0050.00
流动资产(万元)151,515.56156,141.70150,221.58152,546.62154,096.28
流动负债(万元)94,262.21101,379.07102,841.12107,435.48114,577.98
羚锐制药600285评分结果
60.61分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006